Patents by Inventor Henry C. Chiou

Henry C. Chiou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230130038
    Abstract: High-yield mammalian transient expression systems can include a cell culture media (particularly serum free, non-animal derived, and/or chemically defined media) for introducing macromolecules and compounds (e.g., nucleic acid molecules) into cells (e.g., eukaryotic cells). Cells containing such introduced materials can then be cultured in the cell culture media. In particular, the invention allows introduction of nucleic acid molecules (e.g., vectors) into cells (particularly mammalian cells) and expression of proteins encoded by the nucleic acid molecules in the cells. The invention obviates the need to change the cell culture medium each time a different procedure is performed with the cells (e.g., culturing cells vs. transfecting cells). The invention also relates to compositions and kits useful for culturing and transforming/transfecting cells.
    Type: Application
    Filed: October 31, 2022
    Publication date: April 27, 2023
    Inventors: Sanjay K. VASU, Chao Yan LIU, Jeffrey ROGERS, Maria Isabel CISNEROS, Jingqui LI, Henry C. CHIOU, Meredith Bauman JONES
  • Publication number: 20040002466
    Abstract: A molecular complex comprising a gene encoding interferon releasably linked to a conjugate of a nucleic acid binding agent and a ligand which binds to a component on the surface of a cell. In a preferred embodiment, the gene encodes human IFN-&agr;, IFN-&bgr;, or IFN-&ggr;. The complex can be used to obtain targeted expression of interferon in selected cells either in vivo or in vitro.
    Type: Application
    Filed: November 26, 2001
    Publication date: January 1, 2004
    Applicant: The Immune Response Corporation
    Inventors: Henry C. Chiou, Dennis J. Carlo
  • Publication number: 20030134420
    Abstract: The present invention provides novel compositions and formulations for delivering anionic compounds, particularly polynucleotides (DNA and RNA), across cellular boundaries (e.g., cellular membranes) either in vivo or in vitro.
    Type: Application
    Filed: August 2, 2002
    Publication date: July 17, 2003
    Inventors: Charles Peter Lollo, Mariusz Banaszczyk, Henry C. Chiou, Dongpei Wu, Patricia M. Mullein, Alison T. Carlo
  • Patent number: 6331525
    Abstract: A molecular complex comprising a gene encoding interferon releasably linked to a conjugate of a nucleic acid binding agent and a ligand which binds to a component on the surface of a cell. In a preferred embodiment, the gene encodes human IFN-&agr;, IFN-&bgr;, or IFN-&ggr;. The complex can be used to obtain targeted expression of interferon in selected cells either in vivo or in vitro.
    Type: Grant
    Filed: August 23, 1999
    Date of Patent: December 18, 2001
    Assignee: The Immune Response Corporation
    Inventors: Henry C. Chiou, Dennis J. Carlo
  • Patent number: 6069133
    Abstract: A molecular complex comprising a gene encoding interferon releasably linked to a conjugate of a nucleic acid binding agent and a ligand which binds to a component on the surface of a cell. In a preferred embodiment, the gene encodes human IFN-.alpha., IFN-.beta., or IFN-.gamma.. The complex can be used to obtain targeted expression of interferon in selected cells either in vivo or in vitro.
    Type: Grant
    Filed: March 17, 1997
    Date of Patent: May 30, 2000
    Assignee: The Immune Response Corporation
    Inventors: Henry C. Chiou, Dennis J. Carlo